← FDA Drug Approvals (Drugs@FDA)

LITHIUM CARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2010-12-27

Drug application

FDA Application #

ANDA091544

Application type

Abbreviated New Drug Application (Generic)

Brand name

LITHIUM CARBONATE

Generic name

LITHIUM CARBONATE

Active ingredients

LITHIUM CARBONATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2010-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown